Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rossing

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 24, 1998
Doubling of serum creatinine: is it sensitive and relevant?P Rossing
Diabetologia|December 13, 2005
Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005P Rossing
Diabetologia|June 30, 2005
The changing epidemiology of diabetic microangiopathy in type 1 diabetesP Rossing
Diabetic Medicine : a Journal of the British Diabetic Association|November 25, 1998
Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitusP Rossing
Ugeskrift for Laeger|October 3, 2000
[Risk factors in the progression of diabetic nephropathies]P Rossing
Danish Medical Bulletin|October 20, 1998
Promotion, prediction, and prevention of progression in diabetic nephropathyP Rossing
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1993
Calcium antagonists and the diabetic hypertensive patientH H Parving, P Rossing
Diabetes Care|February 24, 2001
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetesH H Parving, P Rossing
Current Opinion in Nephrology and Hypertension|May 1, 1994
The use of antihypertensive agents in prevention and treatment of diabetic nephropathyH H Parving, P Rossing
Diabetes Care|October 17, 1998
Diabetes and risk of adverse events with calcium antagonistsH H Parving, P Rossing
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 24, 1998
Doubling of serum creatinine: is it sensitive and relevant?P Rossing
Diabetologia|December 13, 2005
Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005P Rossing
Diabetologia|June 30, 2005
The changing epidemiology of diabetic microangiopathy in type 1 diabetesP Rossing
Diabetic Medicine : a Journal of the British Diabetic Association|November 25, 1998
Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitusP Rossing
Ugeskrift for Laeger|October 3, 2000
[Risk factors in the progression of diabetic nephropathies]P Rossing
Danish Medical Bulletin|October 20, 1998
Promotion, prediction, and prevention of progression in diabetic nephropathyP Rossing
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1993
Calcium antagonists and the diabetic hypertensive patientH H Parving, P Rossing
Diabetes Care|February 24, 2001
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetesH H Parving, P Rossing
Current Opinion in Nephrology and Hypertension|May 1, 1994
The use of antihypertensive agents in prevention and treatment of diabetic nephropathyH H Parving, P Rossing
Diabetes Care|October 17, 1998
Diabetes and risk of adverse events with calcium antagonistsH H Parving, P Rossing
Pageof 14